Browse our Sections
Faz K. Bashi, MD, has a research background in Immunology and Virology from UCSF. He is Lead Venture Investor for Portfolia’s FemTech Funds I, II and III, focused on Women’s Health and Wellness (www.portfolia.co), an active member of Life Science Angels (www.lifescienceangels.com) in Silicon Valley and an Emeritus Board Member of the Angel Capital Association (ACA;
www.angelcapitalassociation.org) where he continues to Chair the ACA&’s Life Sciences Syndication group. He is active with UCSF’s Entrepreneurship Startup 101 and Lean Launchpad, and serves on the
external advisory board member for UCSF’s Clinical and Translational Science Institute (CTSI) and Johns Hopkins’ Center for BioEngineering and Design (CBID; https://cbid.bme.jhu.edu/). He mentors women entrepreneur leaders for Springboard Enterprises (www.sb.co) Life Sciences Council.
Dr. Bashi is also very active in the Animal/Pet Health entrepreneurial ecosystem and serves as an advisor to One Health Group (www.onehealthgroup.com), with 72 issued patents providing non-contact, highly accurate, medical-grade remote-monitoring animal health data. Dr. Bashi is committed to helping find treatments for Tinnitus, Autism, Lupus, and Vascular diseases. He completed several triathlons with Team-In-Training to raise funds for the Leukemia and Lymphoma Society.
In this report we also introduce the FemAging Tech 20, a list of twenty top companies developing innovations that are helping to meet the unique health and wellness needs of women ages 40+
Key FemAging Index insights include older women's concerns about their ability to remain active, healthy and independent as they age, the menopause treatment gap and why women of color are especially concerned about sexual and bladder health.
FemAging 2020 was commissioned by WisePause, a pioneering health initiative that highlights, celebrates and seeks to improve the mental and physical well-being of women ages 40+.
…and much, much more